Indication

Ulcerative colitis remission

Ulcerative colitis remission describes an inactive clinical state in pediatric and adult patients diagnosed with ulcerative colitis, a chronic inflammatory bowel disease primarily involving mucosal inflammation of the colon and rectum. Read more about Ulcerative colitis remission

60 drugs 40 manufacturers

Advertisement

Drugs that treat it

Common Ulcerative colitis remission therapies.

Showing 1–9 of 60 drugs

SULFASALAZINE

ANTIRHEUMATIC AGENTS (DMARDS, NON-BIOLOGIC)·ULCERATIVE COLITIS·+1
GREENSTONE LLC.
Filter & compare in the drug finder →Opens the drug finder with Ulcerative colitis remission preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Ulcerative colitis remission.

Ulcerative colitis remission describes an inactive clinical state in pediatric and adult patients diagnosed with ulcerative colitis, a chronic inflammatory bowel disease primarily involving mucosal inflammation of the colon and rectum.

As an indication and therapeutic target, remission encompasses the induction or maintenance of complete symptomatic relief—defined by the resolution of rectal bleeding and normalization of stool frequency—ideally accompanied by objective mucosal healing.

At the pathophysiologic level, this quiescent phase is characterized by the down-regulation of mucosal inflammation, endoscopic clearance of erythema, friability, and erosions, and the absence of active neutrophilic infiltration on histologic examination.

Personalize your experience

Follow Ulcerative colitis remission and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it